Dr. Cotliar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12121 Bluff Creek Drive
Suite 100
Los Angeles, CA 90094Phone+1 984-377-3737
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine/Dermatology, 2000 - 2004
Loyola University Medical CenterResidency, Internal Medicine, 1999 - 2000
University of Kentucky College of MedicineClass of 1999
Certifications & Licensure
NM State Medical License 2020 - 2027
AR State Medical License 2020 - 2026
IL State Medical License 1999 - 2026
NY State Medical License 2019 - 2026
TX State Medical License 2019 - 2026
CA State Medical License 2001 - 2025
FL State Medical License 2019 - 2025- American Board of Dermatology Dermatology
- American Board of Internal Medicine Internal Medicine
- Join now to see all
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Sorafenib-induced Hand- Foot Skin Reaction Treatment Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- 56 citationsDevelopment and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10Megan H. Noe, Misha Rosenbach, Rebecca A. Hubbard, Arash Mostaghimi, Adela R. Cardones
JAMA Dermatology. 2019-04-01 - 84 citationsStevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United StatesRobert G. Micheletti, Zelma Chiesa-Fuxench, Megan H. Noe, Sasha Stephen, Maria Aleshin
The Journal of Investigative Dermatology. 2018-11-01 - 24 citationsSociety of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.Lucia Seminario-Vidal, Daniela Kroshinsky, Stephen J. Malachowski, James Sun, Alina Markova
Journal of the American Academy of Dermatology. 2020-06-01
Press Mentions
Science 37® Adds Acclaimed Researcher and Oncologist, Dr. Shaalan Beg to Bolster Therapeutic DepthMarch 31st, 2022- Science 37® Adds Acclaimed Researcher and Oncologist, Dr. Shaalan Beg to Bolster Therapeutic DepthMarch 31st, 2022
- Science 37® and Foundation Medicine Partner to Enable Interventional Home-Based Clinical Trials in OncologySeptember 8th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
